Ovid Therapeutics
OVID
$3.07
Share price
0.33%
Change (1 day)
-15.43%
Change (1 year)
Categories
Ovid Therapeutics (OVID) - Cash on Hand
Cash on Hand as of December 2023 : $0.10 B
According to Ovid Therapeutics
's latest financial reports the company has $0.10 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Ovid Therapeutics - Cash on Hand chart (from 2016 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.10 B | -17.96% |
| 2022-12-31 | $0.12 B | -31.31% |
| 2021-12-31 | $0.18 B | 160.71% |
| 2020-12-31 | $72.03 M | -6.13% |
| 2019-12-31 | $76.73 M | 84.91% |
| 2018-12-31 | $41.5 M | -52.37% |
| 2017-12-31 | $87.12 M | 67.74% |
| 2016-12-31 | $51.93 M | -25.74% |
| 2015-12-31 | $69.94 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | 96.71% | 🇺🇸 USA |